ANAHEIM, Calif., Feb. 19, 2018 /PRNewswire/ -- The Sechrist Veterinary Health Hyperbaric Oxygen Chamber located at The John and Ann Tickle Small Animal Hospital at the University of Tennessee Veterinary Medical Center, in Knoxville, TN is being used in a study that will measure the effects of Hyperbaric Oxygen Therapy (HBOT) on wound healing in canines suffering from snake bites.
The prospective, blinded and controlled study is being conducted to assess the effects of HBOT on local wound swelling, severity and pain. A secondary objective is to describe the safety and effectiveness of HBOT in dogs. All dogs will receive standard care for snake bites, including fluids and pain medication. Dogs will be chosen randomly to be in either the HBOT group or the control group (No HBOT).
Hyperbaric Oxygen Therapy (HBOT) is the therapeutic breathing of 100% oxygen while the body is under increased ambient pressure. It is used as an adjunctive treatment to improve blood and tissue oxygenation and enhance the body's natural antibacterial activity and reduce inflammation. The results of the study will determine if HBOT improves recovery after snake bites.
ABOUT SECHRIST VETERINARY HEALTH
Sechrist Industries Inc., the manufacturer of more monoplace hyperbaric chambers than all other manufacturers combined, currently has the largest installed base in operation within the developed nations. In launching their new Veterinary Health Division, they have landed a spot at the University of Tennessee College of Veterinary Medicine. Sechrist installed a new Model SV500 Veterinary Hyperbaric Chamber to support the study.
Sechrist's Veterinary Hyperbaric Chamber is used to treat, not only the same indications seen in human patients, but also many other conditions unique to animal patients. Sechrist hyperbaric chambers provide constant visual and audible contact while the patient breathes pure oxygen enclosed in a clear hyperbaric environment. Sechrist's Veterinary Hyperbaric Oxygen Chamber is helping to advance the future of small animal health care.
John Razzano, President of Sechrist Veterinary Health said, "Sechrist has an outstanding reputation for quality, trust and service while supporting a strong market leadership position in a rapidly growing market. We are excited to do our part to help advance the therapy of Hyperbaric Oxygen Therapy in the world of veterinary medicine."
To learn more about the UT sponsored snake bite study, visit vetmed.tennessee.edu/vmc. To learn more about Sechrist and their veterinary hyperbaric chambers, go to www.sivethealth.com.
Media Contact: Ryan Stein, 1-714-579-8384; [email protected]
SOURCE Sechrist Veterinary Health